Literature DB >> 10826269

A review of the neuropathology of human spinal cord injury with emphasis on special features.

B A Kakulas1.   

Abstract

A judicious understanding of the basic neuropathology of spinal cord injuries (SCI) is essential knowledge for the clinician responsible for SCI management. An appreciation of the nature of human SCI is also necessary for the neuroscientist searching for a cure. The neuropathology of human SCI described here is derived from the study of 564 cases of spinal cord trauma held in a tissue bank and database of the Department of Neuropathology, Royal Perth Hospital in Australia. The main features of SCI neuropathology are reviewed and special aspects such as early axonal lesions, traumatic demyelination-remyelination, and quantification of white matter tracts are reported in more detail. One of the remarkable outcomes of this work is the finding that the majority of SCI patients have a proportion of spinal cord white matter maintained across the level of the lesion, an observation that has important therapeutic implications.

Entities:  

Mesh:

Year:  1999        PMID: 10826269     DOI: 10.1080/10790268.1999.11719557

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  67 in total

1.  Methods for a randomized trial of weight-supported treadmill training versus conventional training for walking during inpatient rehabilitation after incomplete traumatic spinal cord injury.

Authors:  Bruce H Dobkin; David Apple; Hugues Barbeau; Michele Basso; Andrea Behrman; Dan Deforge; John Ditunno; Gary Dudley; Robert Elashoff; Lisa Fugate; Susan Harkema; Michael Saulino; Michael Scott
Journal:  Neurorehabil Neural Repair       Date:  2003-09       Impact factor: 3.919

2.  Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury.

Authors:  Ellen M Andrews; Rebekah J Richards; Feng Q Yin; Mariano S Viapiano; Lyn B Jakeman
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

3.  MRI and the evaluation of the blood-spinal cord barrier following injury.

Authors:  Eric D Schwartz
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

Review 4.  Cellular transplantation strategies for spinal cord injury and translational neurobiology.

Authors:  Paul J Reier
Journal:  NeuroRx       Date:  2004-10

5.  Characterization of graded multicenter animal spinal cord injury study contusion spinal cord injury using somatosensory-evoked potentials.

Authors:  Gracee Agrawal; Candace Kerr; Nitish V Thakor; Angelo H All
Journal:  Spine (Phila Pa 1976)       Date:  2010-05-15       Impact factor: 3.468

Review 6.  Afferent input and sensory function after human spinal cord injury.

Authors:  Recep A Ozdemir; Monica A Perez
Journal:  J Neurophysiol       Date:  2017-07-12       Impact factor: 2.714

7.  Pre-hospital and acute management of traumatic spinal cord injury in the Netherlands: survey results urge the need for standardisation.

Authors:  B L Fransen; A J Hosman; J J van Middendorp; M Edwards; P M van Grunsven; H van de Meent
Journal:  Spinal Cord       Date:  2015-07-14       Impact factor: 2.772

Review 8.  Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity.

Authors:  Irin C Maier; Martin E Schwab
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

9.  Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations.

Authors:  Bo Chen; Yi Li; Bin Yu; Zicong Zhang; Benedikt Brommer; Philip Raymond Williams; Yuanyuan Liu; Shane Vincent Hegarty; Songlin Zhou; Junjie Zhu; Hong Guo; Yi Lu; Yiming Zhang; Xiaosong Gu; Zhigang He
Journal:  Cell       Date:  2018-07-19       Impact factor: 41.582

Review 10.  Mesenchymal stem cells in the treatment of spinal cord injuries: A review.

Authors:  Venkata Ramesh Dasari; Krishna Kumar Veeravalli; Dzung H Dinh
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.